KalVista Pharmaceuticals, Inc.
KALV
$13.05
-$0.26-1.95%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.87% | 86.49% | -22.09% | -17.17% | 178.36% |
| Total Receivables | 61.04% | -27.27% | 5.17% | 13.08% | -54.10% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.78% | 33.43% | -29.71% | 14.74% | -8.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.60% | 75.59% | -20.54% | -15.09% | 116.79% |
|
|
|||||
| Total Current Assets | -9.60% | 75.59% | -20.54% | -15.09% | 116.79% |
| Net Property, Plant & Equipment | 3.93% | -8.29% | -0.72% | -12.99% | -3.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.61% | 109.52% | 9.42% | 6.70% | 42.82% |
| Total Assets | -9.14% | 71.60% | -19.66% | -14.96% | 106.55% |
|
|
|||||
| Total Accounts Payable | -16.62% | 12.66% | -51.83% | 18.50% | 193.68% |
| Total Accrued Expenses | 49.10% | 18.71% | 49.00% | -16.48% | -16.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 36.91% | -6.05% | 21.60% | -2.92% | 9.69% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 76.33% | 15.57% | -1.10% | -1.74% | 19.23% |
|
|
|||||
| Total Current Liabilities | 76.33% | 15.57% | -1.10% | -1.74% | 19.23% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.18% | -7.21% | -6.28% | -17.07% | -3.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.73% | 387.60% | -2.04% | -4.94% | 13.54% |
|
|
|||||
| Common Stock & APIC | 0.73% | 8.58% | 0.48% | 0.89% | 31.50% |
| Retained Earnings | -8.69% | -8.78% | -8.29% | -8.61% | -10.50% |
| Treasury Stock & Other | -136.14% | 18.25% | 5.86% | 17.75% | -5.89% |
| Total Common Equity | -34.27% | 8.31% | -22.46% | -16.35% | 133.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.27% | 8.31% | -22.46% | -16.35% | 133.21% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.27% | 8.31% | -22.46% | -16.35% | 133.21% |
|
|
|||||